Richtlijnen en literatuur

Richtlijnen

Klik HIER voor de richtlijn 'Klassieke hairy cell leukemie' van de HOVON CLL werkgroep.

Klik HIER voor de richtlijn 'Hairy cell leukemie variant' van de HOVON CLL werkgroep.    

Literatuur

1. Troussard at al. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification and treatment - Annual updates in hematological malignancies. Am J Hematol. 2024; 99: 679-696
2. Grever et al. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia; Blood 2017
3. Ravandi et al. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia; Blood 2011
4. Matutes E, et al. Hairy cell leukaemia-variant: Disease features and treatment. Best Pract Res Clin Haematol 2015; 28(4): 253-63
5. Robak T. Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment. Cancer Treat Rev 2011; 37: 3–10
6. Robak T,  et al. Hairy cell leukaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(suppl 5):v100-v107
7. Thompson PA, Ravandi F. How I manage patients with hairy cell leukaemia. Br J Haematol. 2017 May;177(4):543-556
8. Kreitman RJ, Wilson W, Calvo KR, et al. Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia. Clin Cancer Res. 2013 ;19(24):6873–6881
9. Waterfall JJ, Arons E, Walker RL, et al. High prevalence of MAP2K1 mutations in variant and IGHV4–34-expressing hairy-cell leukemias. Nat Genet. 2014;46(1):8–10
10. Bohn JP, Wanner D, Steurer M. Ibrutinib for relapsed refractory hairy cell leukemia variant. Leuk Lymphoma. 2017 May;58(5):1224-1226

Ga terug naar de HCL homepage of lees meer over HCL:

• Inleiding
• Diagnostiek
• Indeling
• Behandeling
• Respons criteria
• Follow up
• Beheer en wijzigingenhistorie

Ga terug naar de algemene homepage Behandelprotocollen.